#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Primary mediastinal large B-cell lymphoma Lymphangioma Renal disorder Thrombocytopenia Ventricular tachycardia Thyroid cancer metastatic Fibrodysplasia ossificans progressiva Non-Hodgkin's lymphoma unspecified histology aggressive recurrent Haemophilia A without inhibitors Hypersensitivity pneumonitis Neuropathic arthropathy NTRK gene fusion overexpression Breast cancer metastatic Acute leukaemia Meningococcal immunisation More trials…

    Learn about Rare Diseases

    Paraneoplastic neurological syndrome – Diagnostics Small intestine leiomyosarcoma Glomerulonephritis membranous – Trials in Disease Undifferentiated sarcoma – Diagnostics Haemolytic uraemic syndrome – Treatment Synovial sarcoma metastatic – Life with Disease Castleman’s disease – Diagnostics Kearns-Sayre syndrome Hypereosinophilic syndrome – Life with Disease Mucopolysaccharidosis II – Trials in Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Venlafaxine Hydrochloride Crgd-Zw800-1 Ociperlimab Zetomipzomib Filgrastim Olorofim Entinostat CITRIC ACID ANHYDROUS Rct2100 Edg-5506 Sodium Lactate GSKVX000000030825 Istradefylline Donepezil Thiamine Hydrochloride Casimersen Lifileucel Anhydrous Cholestyramine Paroxetine Hydrochloride Methionine More therapies…

    Learn about Your Condition

    Metastases to biliary tract Rhabdoid tumour of the kidney Post procedural swelling IgA nephropathy Angiosarcoma recurrent Choroid melanoma Coronary artery dissection Rectal cancer stage III Labour induction Hepatoblastoma Osteoarthritis Ewing's sarcoma metastatic Erectile dysfunction Testicular germ cell cancer Coronary artery occlusion More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Mental Disorders

  • Ketamine Infusion Study for Symptom Improvement in Patients with Severe Borderline Personality Disorder

    Not yet recruiting

    2 1 1 1
    Investigated Diseases:
    • Borderline personality disorder
    Investigated Drugs:
    • Ketamine Hydrochloride
    France
  • Psilocybin and pimavanserin for adults with major depressive disorder

    Not yet recruiting

    2 1
    Investigated Drugs:
    • Psilocybine
    Spain
  • A study of ketamine hydrochloride as an additional treatment for patients starting standard antidepressants for major depression

    Not recruiting

    2 1 1
    Investigated Diseases:
    • Major depression
    Investigated Drugs:
    • Ketamine Hydrochloride
    Sweden
  • Study of Aticaprant Oral Tablet vs Small IV Dose to Measure How Well It Is Absorbed in Healthy Adults

    Not recruiting

    1 1 1
    Investigated Drugs:
    • Aticaprant
    Belgium
  • Study on Memantine and Aripiprazole for Reducing Negative Symptoms in Patients with First Episode Psychosis

    Not recruiting

    1 1 1
    Investigated Diseases:
    • Psychotic disorder
    Investigated Drugs:
    • Memantine Hydrochloride
    • Aripiprazole
    Denmark
  • Study on Oxytocin and Sodium Chloride for Preventing Drug Relapse in Individuals with Substance Use Disorder

    Not recruiting

    2 1 1
    Investigated Diseases:
    • Substance use disorder
    Investigated Drugs:
    • Oxytocin
    • Sodium Chloride
    Italy
Previous Page
1 … 27 28 29 30 31 … 40
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.


European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.

Numer nieprawidłowy!
Numer nieprawidłowy!